Why do we fail with penicillin in the treatment of group A streptococcus infections?

References

• Bisno A L, Gerber M A, Gwaltney J M, Jr., Kaplan E L, Schwartz R H. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis 1997; 25: 574–83
   PubMed Web of Science ®Google Scholar
• Stollerman G H. Changing streptococci and prospects for the global eradication of rheumatic fever. Perspect Biol Med 1997; 40: 165–89
   PubMed Web of Science ®Google Scholar
• Macris M H, Hartman N, Murray B, Klein R F, Roberts R B, Kaplan E L, et al. Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades. Pediatr Infect Dis J 1998; 17: 377–81
   PubMed Web of Science ®Google Scholar
• Pichichero M E. Group A beta-hemolytic streptococcal infections. Pediatr Rev 1998; 19: 291–302
   PubMedGoogle Scholar
• Holm S E. Reasons for failures in penicillin treatment of streptococcal tonsillitis and possible alternative. Pediatr Infect Dis J 1994; 13: S66–9, (1 Suppl 1) discussion: S78–9.
   Web of Science ®Google Scholar
• Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984; 6: 601–7
   PubMedGoogle Scholar
• Brook I. Penicillin failure and copathogenicity in streptococcal pharyngotonsillitis. J Fam Pract 1994; 38: 175–9
   PubMed Web of Science ®Google Scholar
• Brook I, Gober A E. Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis. Arch Otolaryngol Head Neck Surg 1995; 121: 1405–9
   PubMedGoogle Scholar
• Roos K, Grahn E, Holm S E. Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcus tonsillitis. Scand J Infect Dis 1986; 18: 313–9
   PubMed Web of Science ®Google Scholar
• Standaert B B, Finney K, Taylor M T, Coleman R T, Horowitz C L, Walter S M, et al. Comparison between cefprozil and penicillin to eradicate pharyngeal colonization of group A beta-hemolytic streptococci. Pediatr Infect Dis J 1998; 17: 39–43
   PubMed Web of Science ®Google Scholar
• Pichichero M E, Margolis P A. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J 1991; 10: 275–81
   PubMed Web of Science ®Google Scholar
• Tanz R R, Shulman S T, Sroka P A, Marubio S, Brook I, Yogev R. Lack of influence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis. J Pediatr 1990; 117: 859–63
   PubMed Web of Science ®Google Scholar
• Sprunt K, Redman W. Evidence suggesting importance of role of interbacterial inhibition in maintaining balance of normal flora. Ann Intern Med 1968; 68: 579–90
   PubMed Web of Science ®Google Scholar
• Crowe C C, Sanders E, Longley S. Bacterial interference. II. Role of the normal flora in prevention of colonization by group A streptococcus. J Infect Dis 1973; 128: 527–32
   PubMed Web of Science ®Google Scholar
• Sanders C C, Nelson G E, Sanders W E, Jr. Bacterial interference. IV. Epidemiological determinants of the antagonistic activity of the normal flora against group A streptococci. Infect Immun 1977; 16: 599–603
   PubMed Web of Science ®Google Scholar
• Fujimori I, Goto R, Kikushima K, Hisamatsu K, Murakami Y, Yamada T. Investigation of oral alpha-streptococcus showing inhibitory activity against pathogens in children with tonsillitis. Int J Pediatr Otorhinolaryngol 1995; 33: 249–55
   PubMed Web of Science ®Google Scholar
• Brook I, Gober A E. Interference by aerobic and anaerobic bacteria in children with recurrent group A beta-hemolytic streptococcal tonsillitis. Arch Otolaryngol Head Neck Surg 1999; 125: 552–4
   PubMedGoogle Scholar
• Roos K, Holm S E, Grahn-Hakansson E, Lagergren L. Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis -a randomized placebo-controlled multicentre study. Scand J Infect Dis 1996; 28: 459–62
   PubMedGoogle Scholar
• Gerber M A. Antibiotic resistance in group A streptococci. Pediatr Clin North Am 1995; 42: 539–51
   PubMed Web of Science ®Google Scholar
• Van Asselt G J, Mouton R P, van Boven C P. Penicillin tolerance and treatment failure in group A streptococcal pharyngotonsillitis. Eur J Clin Microbiol Infect Dis 1996; 15: 107–15
   PubMed Web of Science ®Google Scholar
• Eagle H. Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med 1952; 13: 389–99
   PubMed Web of Science ®Google Scholar
• Stevens D L, Bryant-Gibbons A E, Bergstorm R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988; 158: 23–8
   PubMed Web of Science ®Google Scholar
• Stevens D L, Yan S, Bryant A E. Penicillin binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis 1993; 167: 1401–5
   PubMed Web of Science ®Google Scholar
• Gerber M A. Effect of early antibiotic therapy on recurrence rates of streptococcal pharyngitis. Pediatr Infect Dis J 1991; 10: S56–60, (10 Suppl)
   Web of Science ®Google Scholar
• Pichichero M E, Hoeger W, Marsocci S M, Murphy A M, Francis A B, Dragalin V. Variables influencing penicillin treatment outcome in streptococcal tonsillopharyngitis. Arch Pediatr Adolesc Med 1999; 153: 565–70
   PubMedGoogle Scholar
• Gerber M A, Randolph M F, DeMeo K K, Kaplan E L. Lack of impact of early antibiotic therapy for streptococcal pharyngitis on recurrence rates. J Pediatr 1990; 117: 853–8
   PubMed Web of Science ®Google Scholar
• Nguyen L, Levy D, Ferroni A, Gehanno P, Berche P. Molecular epidemiology of Streptococcus pyogenes in an area where acute pharyngotonsillitis is endemic. J Clin Microbiol 1997; 35: 2111–4
   PubMed Web of Science ®Google Scholar
• Falck G, Holm S E, Kjellander J, Norgren M, Schwan A. The role of household contacts in the transmission of group A streptococci. Scand J Infect Dis 1997; 29: 239–44
   PubMed Web of Science ®Google Scholar
• Brook I, Gober A E. Persistence of group A beta-hemolytic streptococci in toothbrushes and removable orthodontic appliances following treatment of pharyngotonsillitis. Arch Otolaryngol Head Neck Surg 1998; 124: 993–5
   PubMedGoogle Scholar
• Begovac J, Bobinac E, Benic B, Desnica B, Maretic T, Basnec A, et al. Asymptomatic pharyngeal carriage of beta-haemolytic streptococci and streptococcal pharyngitis among patients at an urban hospital in Croatia. Eur J Epidemiol 1993; 9: 405–10
   PubMed Web of Science ®Google Scholar
• Kaplan E L, Gastanaduy A S, Huwe B B. The role of the carrier in the treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981; 98: 326–35
   PubMed Web of Science ®Google Scholar
• LaPenta D, Rubens C, Chi E, Cleary P P. Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci U S A 1994; 91: 12115–9
   PubMed Web of Science ®Google Scholar
• Greco R, De Martino L, Donnarumma G, Conte M P, Seganti L, Valenti P. Invasion of cultured human cells by Streptococcus pyogenes. Res Microbiol 1995; 146: 551–60
   PubMed Web of Science ®Google Scholar
• Schlievert P M, Assimacopoulos A P, Cleary P P. Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J Lab Clin 1996; 127: 13–22
   PubMed Web of Science ®Google Scholar
• Österlund A, Engstrand L. Intracellular penetration and survival of Streptococcus pyogenes in respiratory epithelial cells in vitro. Acta Otolaryngol (Stockh) 1995; 115: 685–8
   PubMed Web of Science ®Google Scholar
• Österlund A, Engstrand L. An intracellular sanctuary for Streptococcus pyogenes in human tonsillar epithelium -studies of asymptomatic carriers and in vitro cultured biopsies. Acta Otolaryngol (Stockh) 1997; 117: 883–8
   PubMed Web of Science ®Google Scholar
• Österlund A, Popa R, Nikkilä T, Scheynius A, Engstrand L. Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope 1997; 107: 640–7
   PubMed Web of Science ®Google Scholar
• Molinari G, Talay S R, Valentin-Weigand P, Rohde M, Chhatwal G S. The fibronectin-binding protein of Streptococcus pyogenes, Sfbl, is involved in the internalization of group A streptococci by epithelial cells. Infect Immun 1997; 65: 1357–63
   PubMed Web of Science ®Google Scholar
• Jadoun J, Ozeri V, Burstein E, Skutelsky E, Hanski H, Sela S. Protein Fl is required for efficient entry of Streptococcus pyogenes into epithelial cells. J Infect Dis 1998; 178: 147–58
   PubMed Web of Science ®Google Scholar
• Dombek P E, Cue D, Sedgewick J, Lam H, Ruschkowski S, Finlay B B. High-frequency intracellular invasion of epithelial cells by serotype Ml group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements. Mol Microbiol 1999; 31: 859–70
   PubMed Web of Science ®Google Scholar
• Neeman R, Keller N, Barzilai A, Korenman Z, Sela S. Prevalence of the internalisation-associated gene, prtF1, among persisting group A streptococcus strains isolated from asymptomatic carriers. Lancet 1998; 352: 1974–7
   PubMed Web of Science ®Google Scholar